Alta Partners
| Company type | Private |
|---|---|
| Industry | Venture capital, Biotechnology, Life sciences |
| Founded | 1996 |
| Founder | Guy Nohra |
| Headquarters | San Francisco , United States |
Key people | Dan Janney, Pete Hudson, Bob More, Guy Nohra |
| Products | Venture capital funds |
Alta Partners is a venture capital firm headquartered in San Francisco that focuses its investments mainly within the biotechnology and life science industries.
One of its cofounders, Guy Nohra, relocated to Barcelona, Spain and subsequently established Alta Life Sciences in 2016.
History
At the firm's inception in 1996, Dan Janney became a partner at Alta. Later, in 2017, Pete Hudson and Bob More joined the partnership.
In 2000, Alta introduced two venture capital funds: Alta California Partners III and Alta BioPharma Partners II. The firm secured its ninth fund, named Alta Partners NextGen Fund I, in 2017. Additionally, two healthcare-focused VC funds were initiated in 2004: Alta BioPharma Partners III and ACP IV.
In May 2022, Alta initiated legal proceedings against BRC Inc. (NYSE:BRCC)—the entity resulting from the 2021 merger between SilverBox Capital and Black Rifle Coffee—accusing it of contract violations by denying Alta the ability to exercise warrants. The dispute was resolved in June 2025 when Alta agreed to pay $1 million and received 2,300,100 shares of BRC Class A common stock.
Investments
Among its significant investments are Ellie Mae, Be Inc., Ilex Oncology, Connects Corp, The Medicines Co., Kite Pharmaceuticals, ZS Pharma, Esperion, Allakos, Chemgenx, DeCode, Calistoga, Aerie, Cymabay, Tyra Biosciences, DIspatchHealth, and VIR Biotechnology.
See also
External links
- Alta Partners (official website)